• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

EACR 2024

June 10 - 13, Rotterdam, The Netherlands

The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

The European Association for Cancer Research (EACR) is a registered charity and global scientific community dedicated to the advancement of cancer research. We have been bringing cancer researchers together at our congress and conferences since 1968.

Meet us at booth #4 and check out our posters:

Posters

  • Poster #202 "An vascularized melanoma model for with unidirectional perfusion of circulating immune cells for Advancing Immune-Oncology Research"
    Wednesday, June 11 2024, 18:40 - 20:15
  • Poster #228 "A comprehensive and scalable human liver-on-chip model for fibrosis drug discovery and gene delivery applications"
    Wednesday, June 11 2024, 18:40 - 20:15
  • Poster #773 "Sorafenib And Lenvatinib Induce Vascular Responses In Patient Derived HCC on-Chip Models"
    Wednesday, June 12 2024, 18:40 - 20:15
  • Poster #373 "Influencing drug responses through in vitro tumor microenvironment characteristics"
    Wednesday, June 12 2024, 18:40 - 20:15

 

 

Schedule a meeting with us

 

Link to the conference homepage

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all